Screen Reader Text Size A- A A+
CDSCO logo

Central Drugs Standard Control Organization

Directorate General of Health Services
Ministry of Health & Family Welfare
Government of India
swach bharat logo
  • Home

  • About Us

    • Central Drug Testing Laboratories

    • Contact Us

    • Functions

    • Introduction

    • Seniority List

    • Telephone Directory

    • Values / Strategies

    • Vision/Mission

    • Who's who

  • Act & Rules

    • Drugs and Cosmetics Act, 1940

    • Drugs Rules, 1945

    • Medical Devices Rules, 2017

    • New Drugs and Clinical Trials Rules, 2019

    • Cosmetics Rules, 2020

    • Advisories/Notices/O.Ms./Orders

    • Final Notifications

    • Draft Notifications

    • Guidance documents

  • BA/BE

    • BA/BE

  • Clinical Trial

    • Ethics Committee

    • Global Clinical Trial

    • Serious Adverse Event

  • Biologics

    • Vaccines

    • Blood Products

    • rDNA

    • Stem Cells and Cell based products

  • Cosmetics

    • Cosmetics

  • DTAB-DCC

  • Drugs

    • Fixed Dose Combination

    • Investigational New Drugs

    • New Drugs

    • Subsequent New Drugs

  • International
    Cell

  • Medical Devices
    & Diagnostics

    • InVitro Diagnostics

    • Medical Device

  • Notifications

    • Recruitment & Rules

    • Alerts

    • Archive

    • Circulars

    • Downloads/Documents&Publications

    • Events

    • Gazette Notifications

    • Public Notices

    • Prescribing Information

    • Adverse Drug Reaction
      related Notifications

    • Tenders

    • Vacancies

    • Citizen's Charter

  • Committees

    • ASR Committee

    • Apex Committee

    • DCC

    • DTAB

    • IND

    • Miscellaneous

    • NDAC

    • SEC

    • Technical Committee

  • PRO

  • Post Marketing DSM

×
  • Ayush
    • Ayush
  • Achievements
    • Achievements
  • Blood Centre
    • BloodCentre
  • Committee
    • Apex Committee
    • Committee Functions
    • Committee Meetings
    • DCC
    • DTAB
    • IND Committee
    • Miscellaneous
    • NDAC Committee
    • SEC
    • Technical Committee
  • Indian System of Medicines
    • Traditional Drugs
  • Offices/Divisions
    • Headquarters
      • BA/BE
      • Biologics
      • Central Licences Approving Authority
      • Clinical Trial
      • Cosmetics
      • Ethics Committee
      • Import &Registration
      • International Cell
      • IT Cell
      • Legal Cell
      • Medical Devices & Diagnostics
      • SAE
      • Training Cell
    • Zonal Offices
      • Ahemdabad
      • Baddi
      • Bengaluru
      • Chennai
      • Ghaziabad
      • Hydrabad
      • Kolkata
      • Mumbai
    • Sub Zonal Offices
      • Goa
      • Guwahati
      • Indore
      • Jammu & Kashmir
      • Dehradun
      • Varanasi
      • Visakhapatnam
    • Port
      • Chennai Port
      • Chennai Sea-Port
      • Delhi
      • Hyderabad
      • Indore Port
      • Kolkata Port
      • Mumbai Port
      • Mumbai Sea-Port
      • Cochin Sea-Port
      • Vishakapatnam Sea-Port
      • Krishnapatnam Sea-Port
    • Labs
      • CDL(Kasauli)
      • CDL(Kolkata)
      • CDTL(Chennai)
      • CDTL(Hyderabad)
      • CDTL(Mumbai)
      • RDTL(Chandigarh)
      • RDTL(Guwahati)
  • Pendency Status
    • Pendency Status
  • PvPI
    • PvPI
  • State Drugs Control
    • State Drugs Control
new Notice regarding Guidance for approval Covid-19 vaccine in India for restricted use in emergency situation which are already approved for restricted use by US FDA EMA, UK MHRA, PMDA Japan or which are listed in WHO Emergency use listing 15th April,2021 DCGI Message 202101 Jan 2021 For Medical devices which are under voluntary registrations, the file number generated is the registration number of firm. E-GOV cell at CDSCO CDSCO,HQ accredited with Quality Management Systems IS/ISO 9001:2015 by BIS
  • Home
  • Sitemap
  • About Us
    • Central Drug Testing Laboratories
    • Contact Us
    • Functions
    • Introduction
    • Seniority List
    • Telephone Directory
    • Values / Strategies
    • Vision/Mission
    • Who's who
  • Act & Rules
    • Drugs and Cosmetics Act, 1940
    • Drugs Rules, 1945
    • Medical Devices Rules, 2017
    • New Drugs and Clinical Trials Rules, 2019
    • Cosmetics Rules, 2020
    • Advisories/Notices/O.Ms./Orders
    • Final Notifications
    • Draft Notifications
    • Guidance documents
  • BA/BE
    • BA/BE
  • Clinical Trial
    • Ethics Committee
    • Global Clinical Trial
    • Serious Adverse Event
  • Biologics
    • Vaccines
    • Blood Products
    • rDNA
    • Stem Cells and Cell based products
  • Cosmetics
    • Cosmetics
  • DTAB-DCC
  • Drugs
    • Fixed Dose Combination
    • Investigational New Drugs
    • New Drugs
    • Subsequent New Drugs
  • International
    Cell
  • Medical Devices
    & Diagnostics
    • InVitro Diagnostics
    • Medical Device
  • Notifications
    • Recruitment & Rules
    • Alerts
    • Archive
    • Circulars
    • Downloads/Documents&Publications
    • Events
    • Gazette Notifications
    • Public Notices
    • Prescribing Information
    • Adverse Drug Reaction
      related Notifications
    • Tenders
    • Vacancies
    • Citizen's Charter
  • Committees
    • ASR Committee
    • Apex Committee
    • DCC
    • DTAB
    • IND
    • Miscellaneous
    • NDAC
    • SEC
    • Technical Committee
  • PRO
  • Post Marketing DSM
QUICK LINKS
  • RTI / Gallery /SiteMap
  • Disclaimer / Copyright Policy / PRO
  • Hyper Linking Policy /Terms & Conditions / Privacy Policy / Acts & Rules
  • Accessibility Statement
  • Abbreviations
  • Other Useful Links
Contact Info
  • Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Directorate General of Health Services, Government of India FDA Bhavan, ITO, Kotla Road, New Delhi -110002
  • dci[at]nic[dot]in
  • 91-11-23236973
  • PRO Toll Free No. 1800 11 1454
NAVIGATION
  • Zonal Offices
  • Sub-Zonal Offices
  • Port Offices
  • Central Drug Testing Laboratories
  • Circulars
  • Help

C-DAC Logo Designed, Developed and Maintained by C-DAC